Abzorb Bar
SUN PHARMA 2 - 100 g
Standard delivery
₹153
Distributor inventory | Capsule
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Medicines with the same active ingredient and strength as Acrotac 25MG Cap.
You are viewing
Acrotac 25MG Cap
capsule - 25 mg - 10 S
₹736
₹73.59 per capsule
Intas Pharmaceuticals Ltd · capsule - 25 mg - 10 S · Rx
₹642
₹64.22 per capsule
Acitretin 25 mg (soft gelatin capsule)
Treatment of severe psoriasis (including erythrodermic or pustular psoriasis) and other severe disorders of keratinisation when unresponsive to other therapies.
Acitretin is an oral retinoid that normalizes epidermal cell growth and differentiation. It reduces excessive keratinocyte proliferation and inflammation, improving scaling, thickening and plaque formation.
Take by mouth as prescribed, usually once daily with the main meal (fat-containing food improves absorption). Swallow capsule whole; do not crush or chew. Dose and duration are individualized; follow dermatologist’s advice and attend regular monitoring.
Common side effects of Acrotac 25MG Cap may include:
SUN PHARMA 2 - 100 g
Standard delivery
SUN PHARMA 2 - powder - 120 g
Standard delivery
SUN PHARMA 2 - capsule - 10 mg - 10 S
Standard delivery
SUN PHARMA 2 - 10 S
Standard delivery
SUN PHARMA 2 - 100 mg - 10 S
Standard delivery
SUN PHARMA 2 - tablet - 200 mg - 10 S
Standard delivery
SUN PHARMA 2 - capsule - 130 mg - 10 S
Standard delivery
SUN PHARMA 2 - tablet - 1000 mg - 10 S
Standard delivery
A substitute contains the same active ingredient (salt), in the same strength, as Acrotac 25MG Cap. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Highly teratogenic: contraindicated in pregnancy. Effective contraception is required for women of childbearing potential during treatment and for at least 3 years after stopping; regular pregnancy tests as advised. Do not donate blood during treatment and for 3 years after stopping. Avoid alcohol during treatment and for 2 months after stopping (can increase formation of etretinate and prolong teratogenic risk). Monitor liver function tests and lipid profile; use caution in liver disease, hyperlipidemia, diabetes, obesity. May cause mood changes, pseudotumor cerebri (severe headache/visual changes) and decreased night vision—avoid driving if affected. Avoid excessive sun/UV exposure.